ImageneBio, Inc. (NASDAQ:IMA) Receives Consensus Rating of “Hold” from Brokerages
ImageneBio, Inc. (NASDAQ:IMA – Get Free Report) has earned an average rating of “Hold” from the five analysts that are covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, one has given a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation […]
15 Sep 10:14 · The Markets Daily